On Wednesday, Insperity earned a positive adjustment to its Relative Strength (RS) Rating, from 64 to 72.
IBD's proprietary RS Rating measures technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the market's biggest winners tend to have an 80 or better RS Rating as they begin their biggest price moves. See if Insperity can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Insperity is not currently near a potential buying area. See if the stock goes on to form a promising consolidation that could kick off a new climb.
While the company's bottom line growth declined in the company's most recent quarterly report from -73% to -93%, the top line grew 2%, up from 1% in the prior report.
Insperity earns the No. 14 rank among its peers in the Commercial Services-Outsourcing industry group. ExlService Holdings, Red Violet and HealthEquity are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
